biblio

Export 3 results:
Filters: First Letter Of Last Name is R and Author is Raeder, Andreas F. B.  [Clear All Filters]
2017
M. Weinmueller, Rechenmacher, F., Marelli, U. Kiran, Reichart, F., Kapp, T. G., Raeder, A. F. B., Di Leva, F. Saverio, Marinelli, L., Novellino, E., Munoz-Felix, J. M., Hodivala-Dilke, K., Schumacher, A., Fanous, J., Gilon, C., Hoffman, A., and Kessler, H., “Overcoming the lack of oral availability of cyclic hexapeptides: design of a selective and orally available ligand for the integrin alpha v beta 3”, Angewandte Chemie-International Edition, vol. 56, no. 51, pp. 16405-16409, 2017.
2018
T. G. Kapp, Di Leva, F. Saverio, Notni, J., Raeder, A. F. B., Fottner, M., Reichart, F., Reich, D., Wurzer, A., Steiger, K., Novellino, E., Marelli, U. Kiran, Wester, H. - J., Marinelli, L., and Kessler, H., “N-Methylation of isoDGR peptides: discovery of a selective alpha 5 beta 1-integrin ligand as a potent tumor imaging agent”, Journal of Medicinal Chemistry, vol. 61, no. 6, pp. 2490-2499, 2018.
2019
F. Reichart, Maltsev, O. V., Kapp, T. G., Raeder, A. F. B., Weinmueller, M., Marelli, U. Kiran, Notni, J., Wurzer, A., Beck, R., Wester, H. Juergen, Steiger, K., Di Maro, S., Di Leva, F. Saverio, Marinelli, L., Nieberler, M., Reuning, U., Schwaiger, M., and Kessler, H., “Selective targeting of integrin alpha v beta 8 by a highly active cyclic peptide”, Journal of Medicinal Chemistry, vol. 62, no. 4, pp. 2024-2037, 2019.